Article info

Download PDFPDF
Extended report
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

Authors

  1. Correspondence to Professor Timothy B Niewold, Division of Rheumatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA; niewold.timothy{at}mayo.edu
View Full Text

Citation

Wampler Muskardin T, Vashisht P, Dorschner JM, et al
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

Publication history

  • Received May 28, 2015
  • Revised September 17, 2015
  • Accepted October 18, 2015
  • First published November 6, 2015.
Online issue publication 
December 09, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.